A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations

Clinical trial NCT05242822 · TERMINATED

Trial details

NCT number: NCT05242822
Sponsor: Kinnate Biopharma
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Intrahepatic Cholangiocarcinoma Urothelial Carcinoma

Start date: 2022-03-29
Primary completion: 2024-10-03
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.